# Severe Hepatitis Intervention With Emapalumab for Liver Disease

> **NCT07744919** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Children's Healthcare of Atlanta** · enrollment: 28 (estimated)

## Conditions studied

- Hepatitis

## Interventions

- **DRUG:** Emapalumab

## Key facts

- **NCT ID:** NCT07744919
- **Lead sponsor:** Children's Healthcare of Atlanta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2031-09
- **Final completion:** 2032-09
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07744919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07744919, "Severe Hepatitis Intervention With Emapalumab for Liver Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07744919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*